Hendrickson, Whitney K., and Cindy L. Amundsen. “Sacral neuromodulation: sacral anatomy and optimal lead placement.” Int Urogynecol J 32, no. 9 (September 2021): 2545–47. https://doi.org/10.1007/s00192-020-04615-8.
Cindy Louise Amundsen, MD
Roy T. Parker, M.D. Distinguished Professor of Obstetrics and Gynecology, in the School of Medicine
Campus Mail:
5324 McFarland Drive Suite 310, Box 3192, Durham, NC 27617
Phone:
(919) 401-1006
Email:
cindy.amundsen@duke.edu
- Application of nerve stimulation (Interstim therapy) for control of continence
- Evaluation of botox therapy for urinary urge incontinence
- Evaluation and treatment for nocturnal voiding
- Application of nerve stimulation for control of continence and enable proper voiding in individuals with Spinal cord injuries
- Application of nerve stimulation for urinary retention
- Minimally invasive prolapse surgery using graft material for enhancing pelvic organ prolapse repairs
-Treatment for stress urinary incontinence with minimally invasive techniques
- Evaluation of the urinary microbiome as it relates to recurrent urinary tract infections and lower urinary tract symptoms
Education and Training
- Urogynecology Fellowship, Surgery, University of Texas Health Science Center San Antonio, 1995 - 1996
- Residency, Obstetrics & Gynecology, University of Texas Health Science Center San Antonio, 1991 - 1995
- M.D., University of Tennessee Health Science Center, 1991
Certifications
- American Board of Obstetrics and Gynecology, 1997
- Female Pelvic Medicine and Reconstructive Surgery, 2013
Research
Lower Urinary Tract Dysfunction / Pelvic Floor Disorders
Selected Grants and Awards
- Duke Women's Reproductive Health Research Scholars
- Advancing the Measurement and Classification of Lower Urinary Tract Dysfunction
- AUGS/DUKE Urogynecology Clinical Research Educational Scientist Training (UrogynCREST) Program
- A prospective study to assess the efficacy and safety of the BlueWind RENOVA iStim System in the treatment of patients diagnosed with overactive bladder (OASIS - OverActive bladder StImulation System
- Predicting Urinary Continence Status with Sacral Neuromodulation and Botulinum Toxin Treatments
- Duke KURe Program - Supplement
- Underactive Bladder: Mechanisms and Recovery of Sensation and Function
- Building Interdisciplinary Research Careers in Women's Health
- Duke University Medical Center (DUMC) Pelvic Floor Disorders Network (PFDN) Clinical Site
- Effects of Aging and the Urinary Microbiome on Recurrent Urinary Tract Infections
- Model for Predicting Efficacy of Treatment and Complications in Women after Intradetrusor OnabotulinumtoxinA for Non-Neurogenic Urgency Incontinence"
- Epigenomics in insulin resistance associated overactive bladder
- Neural Prosthetic Control of Continence and Micturition
- Combination Therapy in the Treatment of Urge Urinary Incontinence: A Randomized, Placebo Controlled Trial
- Symptoms of Lower Urinary Tract Dysfunction Research Network (U01) Supplement
- The Jahnigen Career Development Award (JCDA)
- Nocturnal Deterusor Overactivity In Overactive Bladder Syndrome
- The Effect of Androgens on Sexual Function in Women with Polycystic Ovarian Syndrome
Publications
Hendrickson, Whitney K., and Cindy L. Amundsen. “Sacral neuromodulation: troubleshooting needle placement.” International Urogynecology Journal 32, no. 9 (September 2021): 2549–51. https://doi.org/10.1007/s00192-020-04614-9.
Bowen, Shaniel T., Pamela A. Moalli, Steven D. Abramowitch, Mark E. Lockhart, Alison C. Weidner, Cecile A. Ferrando, Charles W. Nager, et al. “Defining mechanisms of recurrence following apical prolapse repair based on imaging criteria.” Am J Obstet Gynecol, June 1, 2021. https://doi.org/10.1016/j.ajog.2021.05.041.
Dieter, Alexis A., Margaret G. Mueller, Uduak U. Andy, Anna C. Kirby, Denicia S. Dwarica, Cindy L. Amundsen, W Thomas Gregory, et al. “Baseline Characteristics, Evaluation, and Management of Women With Complaints of Recurrent Urinary Tract Infections.” Female Pelvic Med Reconstr Surg 27, no. 5 (May 1, 2021): 275–80. https://doi.org/10.1097/SPV.0000000000001065.
Bickhaus, J. A., M. S. Bradley, C. L. Amundsen, A. G. Visco, T. Truong, Y. J. Li, and N. Y. Siddiqui. “Does a recent urinary tract infection increase the risk of postprocedure urinary tract infection after onabotulinum toxin a?” Obstetrical and Gynecological Survey 76, no. 5 (May 1, 2021): 267–68. https://doi.org/10.1097/01.ogx.0000751432.28331.65.
Karstens, Lisa, Nazema Y. Siddiqui, Tamara Zaza, Alecsander Barstad, Cindy L. Amundsen, and Tatyana A. Sysoeva. “Benchmarking DNA isolation kits used in analyses of the urinary microbiome.” Sci Rep 11, no. 1 (March 17, 2021): 6186. https://doi.org/10.1038/s41598-021-85482-1.
Hendrickson, Whitney K., Cindy L. Amundsen, David D. Rahn, Isuzu Meyer, Megan S. Bradley, Ariana L. Smith, Deborah L. Myers, J Eric Jelovsek, and Emily S. Lukacz. “Comparison of 100 U With 200 U of Intradetrusor OnabotulinumToxinA for Nonneurogenic Urgency Incontinence.” Female Pelvic Med Reconstr Surg 27, no. 3 (March 1, 2021): 140–46. https://doi.org/10.1097/SPV.0000000000001020.
Bickhaus, Jennifer A., Megan S. Bradley, Cindy L. Amundsen, Anthony G. Visco, Tracy Truong, Yi-Ju Li, and Nazema Y. Siddiqui. “Does a Recent Urinary Tract Infection Increase the Risk of Postprocedure Urinary Tract Infection After Onabotulinum Toxin A?” Female Pelvic Med Reconstr Surg 27, no. 2 (February 1, 2021): 121–25. https://doi.org/10.1097/SPV.0000000000000753.
Bickhaus, Jennifer A., Matthew O. Fraser, Alison C. Weidner, Friederike L. Jayes, Cindy L. Amundsen, Ken Gall, Frank C. Marini, Stanley J. Robboy, and Nazema Y. Siddiqui. “Evaluation of Host Immune Cellular and Extracellular Matrix Responses to Prolapse Mesh With and Without Tension in a Rat Model.” Female Pelvic Med Reconstr Surg 27, no. 2 (February 1, 2021): e385–91. https://doi.org/10.1097/SPV.0000000000000943.
Hendrickson, Whitney K., Gongbo Xie, David D. Rahn, Megan Bradley, Vivian Sung, Jim A. Hokanson, Ariana L. Smith, et al. “MODELS FOR PREDICTING EFFICACY OF TREATMENT AND COMPLICATIONS IN WOMEN AFTER INTRADETRUSOR ONABOTULINUMTOXINA FOR NON-NEUROGENIC URGENCY INCONTINENCE.” In Neurourology and Urodynamics, 40:S72–74, 2021.